Seegene Holds Partner Executive Roundtable with Microsoft and Springer Nature
Accelerating Technology-Sharing Initiative
On October 23, the three companies convened at Springer Nature London Campus to
share initial achievements and explore strategies for further collaboration.
Funds and tech to innovate syndromic PCR for a healthier world,
in partnership with Seegene, now open for applications
Explore our advanced real-time PCR assays,
designed for precise detection of Monkeypox
Novaplex™ MPXV/OPXV Assay*
Novaplex™ HSV-1&2/VZV/MPXV Assay*
Novaplex™ MPXV/OPXV plus Assay*
*For research use only. Not for use in diagnostic procedures
Our syndromic qPCR approach
Detect up to 14 pathogens in a single test and experience easier workflow
with Seegene’s All-in-One system
Discover our OneSystem™ business
This is an unprecedented worldwide initiative empowering scientists and experts
for a world free from all diseases
Open Innovation Program powered by Seegene
Awardees Announced
This initiative marks the beginning of Seegene's endeavor to realize a world free from all diseases.
Join us on the journey as each awardee carries out highly impactful clinical studies in molecular diagnosis.
Seegene Announces Collaboration with Microsoft
to Realize ‘A World Free from All Diseases’
Strategic collaboration will open a new chapter in the field of molecular diagnostics by digitally enhancing SGDDS
with the integration of Microsoft Azure AI solutions and will improve the healthcare ecosystem,
providing the foundation for effective treatment and prevention.
Experience the Advanced
HPV Test Solution
Allplex™ HPV HR Detection
HPV assay for cervical cancer screening
Seegene STARlet-AIOS™
One streamlined automated system
for all high multiplex real-time PCR assays
Unveil the world’s first commercialized
‘3 Ct’ PCR assay
1 tube, 15 targets with individual Ct values